Daewoong Pharmaceutical has partnered with Chong Kun Dang for local sales of the gastroesophageal reflux disease (GERD) treatment Fexuclue, the country’s 34th new drug, the company said Monday. Fexuclue is a potassium-competitive acid blocker (P-CAB)-based GERD treatment that is designed to improve the shortcomings of proton pump inhibitor (PPI) drugs, such as slow onset of action and dietary effects. P-CABs ha.
Daewoong Pharmaceutical, South Korea’s leading pharmaceutical company, is expected to appoint Vice President Park Seong-soo as its new co-CEO during its annual shareholders meeting in March, according to industry sources Wednesday. “Daewoong aims to accelerate the expansion of its overseas businesses with Park's appointment,” a source familiar with the internal matter said on condition of anony.
/PRNewswire/ Daewoong Pharmaceutical (CEO Jeon Seng-ho, Lee Chang-jae) announced that Fuxuprazan is officially launched in the Philippines on the 27th..
Daewoong Pharmaceutical Co., Ltd.: Daewoong Pharmaceutical has obtained approval for SGLT2i + metformin combination drug Envlomet finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Daewoong Pharmaceutical has obtained approval for SGLT2i + metformin combination drug Envlomet thecambodianews.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thecambodianews.net Daily Mail and Mail on Sunday newspapers.